Tuesday, Aug 24, 1999
South San Francisco, Calif. -- August 24, 1999 --Genentech, Inc. (NYSE: DNA) today announced the promotion of James Panek to senior vice president, Product Operations. Panek will report to William D. Young, chief operating officer. In this new position, Panek will oversee the Manufacturing, Process Sciences, Quality, Engineering and Facilities organizations at Genentech.
"This appointment acknowledges Jim's high level of expertise and experience and the important contributions he has made to the company," said Young. "This position brings together, under Jim's direction, all of the groups that are responsible for making certain that Genentech continues to supply high quality products to patients. With his demonstrated knowledge and leadership ability, I am confident Product Operations will continue to be one of Genentech's key strengths."
Panek, 46, has been with Genentech for 17 years and has held various positions including development project team leader for human growth hormone, director of Engineering and senior director of Engineering and Facilities. Panek was most recently vice president of Manufacturing, Engineering and Facilities and was responsible for the design, construction and maintenance of all Genentech facilities including Genentech's new manufacturing plant in Vacaville, Calif.
Panek holds a bachelor's and a master's degree in chemical engineering from the University of Michigan. Prior to joining Genentech, Panek spent six years with Eli Lilly in a variety of engineering and development positions.
Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Twelve of the currently marketed biotechnology products stem from Genentech science. Genentech markets seven products directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA.
# # #